vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与UMH PROPERTIES, INC.（UMH）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是UMH PROPERTIES, INC.的1.1倍（$75.5M vs $67.0M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 8.2%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 7.8%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
UMH Properties, Inc.是一家公开上市的股权型房地产投资信托（REIT），主营移动房屋社区的持有与运营，目前自有项目涵盖美国12个州的135个移动房屋社区，共约25700个已开发住宅地块；此外该公司还与路孚实地产合资，在佛罗里达州持有运营另外两个社区。
PBYI vs UMH — 直观对比
营收规模更大
PBYI
是对方的1.1倍
$67.0M
营收增速更快
PBYI
高出19.5%
8.2%
两年增速更快
PBYI
近两年复合增速
7.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $67.0M |
| 净利润 | — | $4.6M |
| 毛利率 | 69.3% | — |
| 营业利润率 | 22.7% | — |
| 净利率 | — | 6.8% |
| 营收同比 | 27.7% | 8.2% |
| 净利润同比 | — | -8.1% |
| 每股收益（稀释后） | $0.26 | $-0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIUMH
| Q4 25 | $75.5M | $67.0M | ||
| Q3 25 | $54.5M | $66.9M | ||
| Q2 25 | $52.4M | $66.6M | ||
| Q1 25 | $46.0M | $61.2M | ||
| Q4 24 | $59.1M | $61.9M | ||
| Q3 24 | $80.5M | $60.7M | ||
| Q2 24 | $47.1M | $60.3M | ||
| Q1 24 | $43.8M | $57.7M |
净利润PBYIUMH
| Q4 25 | — | $4.6M | ||
| Q3 25 | $8.8M | $9.3M | ||
| Q2 25 | $5.9M | $7.6M | ||
| Q1 25 | $3.0M | $4.8M | ||
| Q4 24 | — | $5.0M | ||
| Q3 24 | $20.3M | $12.9M | ||
| Q2 24 | $-4.5M | $5.2M | ||
| Q1 24 | $-4.8M | $-1.6M |
毛利率PBYIUMH
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
营业利润率PBYIUMH
| Q4 25 | 22.7% | — | ||
| Q3 25 | 17.6% | — | ||
| Q2 25 | 12.7% | — | ||
| Q1 25 | 8.7% | — | ||
| Q4 24 | 22.6% | — | ||
| Q3 24 | 27.4% | — | ||
| Q2 24 | -4.6% | — | ||
| Q1 24 | -5.3% | — |
净利率PBYIUMH
| Q4 25 | — | 6.8% | ||
| Q3 25 | 16.2% | 13.9% | ||
| Q2 25 | 11.2% | 11.4% | ||
| Q1 25 | 6.5% | 7.9% | ||
| Q4 24 | — | 8.0% | ||
| Q3 24 | 25.2% | 21.3% | ||
| Q2 24 | -9.6% | 8.6% | ||
| Q1 24 | -11.0% | -2.8% |
每股收益（稀释后）PBYIUMH
| Q4 25 | $0.26 | $-0.01 | ||
| Q3 25 | $0.17 | $0.05 | ||
| Q2 25 | $0.12 | $0.03 | ||
| Q1 25 | $0.06 | $0.00 | ||
| Q4 24 | $0.40 | $0.00 | ||
| Q3 24 | $0.41 | $0.11 | ||
| Q2 24 | $-0.09 | $0.01 | ||
| Q1 24 | $-0.10 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $72.1M |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $905.5M |
| 总资产 | $216.3M | $1.7B |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYIUMH
| Q4 25 | $97.5M | $72.1M | ||
| Q3 25 | $94.4M | $34.1M | ||
| Q2 25 | $96.0M | $79.2M | ||
| Q1 25 | $93.2M | $35.2M | ||
| Q4 24 | $101.0M | $99.7M | ||
| Q3 24 | $96.7M | $66.7M | ||
| Q2 24 | $96.8M | $39.5M | ||
| Q1 24 | $107.2M | $39.9M |
总债务PBYIUMH
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYIUMH
| Q4 25 | $130.3M | $905.5M | ||
| Q3 25 | $115.3M | $924.7M | ||
| Q2 25 | $104.7M | $932.0M | ||
| Q1 25 | $97.1M | $912.4M | ||
| Q4 24 | $92.1M | $914.0M | ||
| Q3 24 | $71.1M | $856.5M | ||
| Q2 24 | $48.5M | $742.0M | ||
| Q1 24 | $51.0M | $715.1M |
总资产PBYIUMH
| Q4 25 | $216.3M | $1.7B | ||
| Q3 25 | $202.9M | $1.6B | ||
| Q2 25 | $194.9M | $1.6B | ||
| Q1 25 | $196.2M | $1.5B | ||
| Q4 24 | $213.3M | $1.6B | ||
| Q3 24 | $220.7M | $1.5B | ||
| Q2 24 | $205.0M | $1.4B | ||
| Q1 24 | $214.1M | $1.4B |
负债/权益比PBYIUMH
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $82.0M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | — |
| 自由现金流率自由现金流/营收 | 19.1% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | 17.92× |
| 过去12个月自由现金流最近4个季度 | $41.7M | — |
8季度趋势，按日历期对齐
经营现金流PBYIUMH
| Q4 25 | $14.4M | $82.0M | ||
| Q3 25 | $9.7M | $23.4M | ||
| Q2 25 | $14.1M | $24.4M | ||
| Q1 25 | $3.6M | $12.8M | ||
| Q4 24 | $15.6M | $81.6M | ||
| Q3 24 | $11.0M | $16.7M | ||
| Q2 24 | $1.0M | $18.6M | ||
| Q1 24 | $11.2M | $19.0M |
自由现金流PBYIUMH
| Q4 25 | $14.4M | — | ||
| Q3 25 | $9.7M | — | ||
| Q2 25 | $14.1M | — | ||
| Q1 25 | $3.6M | — | ||
| Q4 24 | $15.6M | — | ||
| Q3 24 | $11.0M | — | ||
| Q2 24 | $1.0M | — | ||
| Q1 24 | — | — |
自由现金流率PBYIUMH
| Q4 25 | 19.1% | — | ||
| Q3 25 | 17.7% | — | ||
| Q2 25 | 26.8% | — | ||
| Q1 25 | 7.7% | — | ||
| Q4 24 | 26.4% | — | ||
| Q3 24 | 13.7% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | — | — |
资本支出强度PBYIUMH
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
现金转化率PBYIUMH
| Q4 25 | — | 17.92× | ||
| Q3 25 | 1.10× | 2.53× | ||
| Q2 25 | 2.41× | 3.21× | ||
| Q1 25 | 1.21× | 2.66× | ||
| Q4 24 | — | 16.39× | ||
| Q3 24 | 0.54× | 1.30× | ||
| Q2 24 | — | 3.58× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
